How many investments has Synthesis Capital made?

Synthesis Capital has 16 tracked investments.

What stage does Synthesis Capital invest at?

Synthesis Capital invests at the Series A, Series B, Series C stages.

What sectors does Synthesis Capital focus on?

Synthesis Capital focuses on AgTech, Biotech, FoodTech, New Materials.

Where is Synthesis Capital located?

Synthesis Capital is headquartered in London, GB.

Does Synthesis Capital lead rounds?

Yes, Synthesis Capital leads investment rounds.

Who does Synthesis Capital co-invest with?

Synthesis Capital most often shares deals with Stray Dog Capital, K3 Ventures, Felicis Ventures, among 44 tracked co-investors.

Synthesis Capital

Venture capital

London · Series A–Series C · 17 people tracked

Also known as Synthesis Capital Advisers Llp · SYNTHESIS CAPITAL LLP

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Synthesis Capital

Paths you didn't know you had: your email and LinkedIn already hold routes to the Synthesis Capital team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

Synthesis Capital invests in the future of food, backing category-leading technologies and platforms that reinvent how food is made, scaled, and consumed. The firm believes the sector's opportunity is driven not by isolated products but by the underlying technologies that reinvent and connect them. It points to a favorable entry point for investors, citing reset valuations, rapid scientific progress, and evolving regulation. The team is described as a global group of investors, founders, and scientists with decades of experience in the food industry.

Invests inAgTech Biotech FoodTech New Materials Europe Global Israel London United Kingdom United States

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Series A–Series C

London, GB

Leads rounds

Leads

Instruments

Equity

Founded

2020

AUM

$300M

VC funds

Tracked investments

Team · 17 people

from the firm's website & public directories

David Welch· Chief Scientific Officer and Co-Founder· Frederick, Maryland, United Statesin

Member of the Synthesis Capital team, formerly connected to the Good Food Institute, who works closely with portfolio companies and advisors.

Costa Yiannoulis· Managing Partner· Londonin 𝕏

Costa Yiannoulis leverages deep technical expertise in fermentation, cultivated meat and biomanufacturing—built a global alt‑protein portfolio—to back foundational science and platform companies tackling scale‑up and capacity bottlenecks.

costa.yiannoulis@synthesis.capital

Rosie Wardle· Partner· Londonin 𝕏

Rosie Wardle is a Kauffman Fellow, a member of Class 31 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at Synthesis Capital in United Kingdom.

rosie.wardle@synthesis.capital

Shivani Oberoi· Principal· London, England, United Kingdomin

Shivani Oberoi is a Principal at Synthesis Capital. She has more than nine years of experience across institutional endowment management and venture capital.

shivani.oberoi@synthesis.capital

Andreas Hadjiyannis· Director of Finance and Operations· London, England, United Kingdomin

Georgina Sánchez Moles· Analyst· London, England, United Kingdomin

Georgina Sánchez Moles is an Analyst at Synthesis Capital, where she focuses on the alternative protein sector. Her areas of interest include plant-based, single-cell, recombinant, and cultivated food technologies.

Gina Boswell· Advisory Board· United Statesin

Mark Matlock· Advisor· Decatur, Illinois, United Statesin

Mark Matlock spent over four decades at Archer Daniels Midland (ADM), where he advanced from analytical chemist to Senior Vice President of Food Research. He directed research on food ingredients and applications, oversaw the commercialization of multiple novel ingredients including xanthan gum and trans-free solid fats, and was instrumental in several major ADM acquisitions. He now advises Synthesis Capital on portfolio companies and investment opportunities in the food ingredient and alternative protein sectors.

Sharon Walbert· Advisory Board· Greater Chicago Areain

Sharon Walbert is a business advisor and board member with commercial, technical, and business leadership experience in the food, agriculture, and sustainable biotechnology sectors. She currently serves as an advisor at Synthesis Capital, where her work spans global commercial and technology strategy. Her background includes experience in product and process innovation, sales, and revenue growth across international markets.

Will Davis· Operations and Culture (Consultant)· London, England, United Kingdomin

Will Davis is Director of Exhibitions and Artist Liaison at Alison Jacques, and has worked as an independent arts management consultant for over a decade with artists, collections, estates, galleries, museums and curators internationally. From 2022 to 2024 he led the digital strategy for UniCredit's corporate art collection, and his earlier roles include COO and Executive Director of the Interspecies Internet's UK and US charitable organisations, Studio Director for artist Eddie Peake, and liaison for Galleria Lorcan O'Neill's UK artists. He has also managed the estate of Maeve Gilmore and worked on the art collection of Jeremy Coller.

Zubin Siganporia· Advisory Board· Greater London, England, United Kingdomin

Zubin Siganporia is a mathematician and Director at QED Analytics, where he works on industrial modelling and analytics projects and advises firms on artificial intelligence, machine learning, data analytics, and optimisation. He holds roles at Oxford University involving mathematics and teaching, sits on the advisory board for the National Academy of Mathematical Sciences, is a De Morgan supporter of the London Mathematical Society, and serves as a spokesperson for the Campaign for Mathematical Sciences. He is an invited speaker on data analytics and AI, delivered a keynote at a data science and AI conference in 2018, and has been involved in school outreach in mathematics and science.

Cara McErlane· Director

Constantinos Yiannoulis· Executive Officer

Elizabeth Burne· Director

Jonathan Hunter· Director

Rose Wardle· Executive Officer

Amanda Schaible· Senior Associate· London Area, United Kingdomin

amanda.schaible@synthesis.capital

What they invest in

from 12 of 16 portfolio companies

FoodTech ×9Biotech ×6AI & Machine Learning ×4Deep Tech ×3New Materials ×3AgTech ×2Circular Economy ×2Climate Tech ×2

HQs:United States×8Israel×1

Who they back

founder profiles across 8 portfolio companies

50%

solo founders

4 of 8 mapped founding teams

Founding team size:solo founder×42 founders×23 founders×14+ founders×1

What their founders studiedfrom 10 founders with field-of-study data

Engineering ×4Life Sciences ×3

Investments · 16 tracked

founders shown can be your intro path

By year:2024 · 2 2023 · 1 2022 · 2 2021 · 1 2020 · 28 dated

Gathered Foodsgatheredfoods.com inDec 2020SEC filingmedium confidence

Gathered Foods makes plant-based food products, positioning its brands around vegan eating, animal welfare, and environmental sustainability.

Advanced ManufacturingAI & Machine LearningConsumerFoodTechImpact & Social GoodHeath, US

William Chris Kerr(Executive Officer, Director)Chad Sarno(Director)inMark Langley(Executive Officer)Christine A. Mei(Executive Officer, Director)

BoardCourtney Reum(Director)Charles Laue(Director)in

Board seat Costa Yiannoulis· per SEC Form D · $30M raise · filed Apr 2021

Co-investorsBlue Horizon Corporation Siddhi Capital Stray Dog Capital Unovis Asset Management Big Idea Ventures CPT Capital +3 more

Culture Biosciencesculturebiosciences.com in 𝕏

Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.

AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US

Will Patrick(CEO)in Matt Ball(CTO)inJonathan Meed(Senior Software Engineer)Satshabad Khalsa(Software Engineer)Andre Castillo(Director of Hardware Operations, Manufacturing and Quality)Fre Tachea(Director of Fermentation)

Co-investorsCompound DCVC (Data Collective)GRIDS Capital Hemisphere Ventures LLC Team Builder Ventures The E14 Fund +20 more

Equi Nomequi-nom.comDec 2022 · $35M

Equinom builds AI-powered software that analyzes grain and flour data to help millers and industrial bakeries predict ingredient performance and manage natural variability in wheat.

AgTechAI & Machine LearningFoodTech

Co-investorsMaverick Ventures Israel BASF Venture Capital GmbH CPT Capital

Geltorgeltor.com in 𝕏Series B · Jul 2020 · $91M

Geltor uses a proprietary biodesign and precision fermentation platform to create and commercially produce novel protein ingredients, including collagens, for beauty and personal care formulators.

BiotechFoodTechNew MaterialsWellness & Fitness

Alexander Lorestani(Founder)inNick Ouzounov(Founder)inNicholas Ouzounov(Founder)

Co-investorsAgronomics Alwyn Capital Argonautic Ventures Baruch Future Ventures Blue Horizon Corporation BoxGroup +19 more

Hyfehyfe.tech in

Hyfé operates a refining process that extracts specialty ingredients and chemical building blocks from food-processing waste and biomass.

Circular EconomyFoodTechNew MaterialsChicago, US

Michelle Ruiz(Executive Officer, Director)inAndrea Schoen(Executive Officer)

Co-investorsOverwater Ventures Llc Chemistry Craft Ventures Pace Capital The Engine Ventures

Mozzamozzafoods.com in 𝕏Mar 2024

Mozza Foods develops casein protein grown in soybeans as an ingredient for the dairy industry, aiming to replace cow-dependent supply chains using existing agricultural infrastructure.

AgTechBiotechFoodTechLos Angeles, US

Adam Tarshis(Founder)inNatasha Sharma(Director)

BoardRose Eva Wardle(Director)

Co-investorsAlumni Ventures Lever VC Stray Dog Capital True Ventures VegInvest CPT Capital

New Culturenewculture.com in 𝕏Nov 2021

New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.

Climate TechFoodTechSan Leandro, US

Matthew Gibson(Executive Officer, Director)in Inja Radman(Founder)inMatt Gibson(Founder)Matt Gibson Inja Radman(Founder)

BoardSteve Sanger(Director)

Co-investorsAhren Innovation Capital Asymmetry Ventures Bee Partners Genoa Ventures S2G Investments CPT Capital +1 more

Perfect Dayperfectday.com in 𝕏

Taking the guesswork out of making perfect coffee

Berkeley, US

Perumal Gandhi(Founder)in Ryan Pandya(Founder)inSonny Vu(Director)Zhang Haorui(Director)

BoardKang Tzu Ping(Director)

Co-investorsAidenlair Capital Felicis Ventures Horizons Ventures K3 Ventures Manta Ray Ventures CPP Investments +5 more

Pow.Biopow.bio in 𝕏

Pow.Bio develops a high-efficiency continuous fermentation platform for biomanufacturing that enables production of biotech products at lower cost and faster timelines.

BiotechDeep Tech

Shannon Hall(Founder)inOuwei Wang(Founder)inOuwei Wang Shannon Hall(Founder)

Co-investorsBetter Ventures Central Llc Hitachi Ventures iSelect Fund Juniper Vectors Angel Bee Partners +3 more

Redefine Meatredefinemeat.com inJan 2022 · $135M

Redefine Meat develops plant-based meat products engineered to replicate premium cuts through proprietary 3D extrusion technology.

Climate TechConsumerDeep TechFoodTechNew MaterialsIsrael, IL

Eshchar Ben-Shitrit(Founder)inAdam Lahav(Founder)

Co-investorsClaltech Hanaco Venture Capital K3 Ventures K3V Ventures Alabaster CPT Capital +1 more

Savorsavor.it inSeries A · Feb 2024 · $23M

Savor produces sustainable fats and oils from non-animal sources for food manufacturing and consumer use.

Circular EconomyCleantechFoodTech

Kathleen C. Alexander(Founder)in

Co-investorsBreakthrough Energy Ventures

TripleBar Bio, Inc.triplebar.com in 𝕏Oct 2023

Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics.

AI & Machine LearningBiotechDeep TechEmeryville, US

Jeremy Agresti(Founder)inHoward Levin(Director)Maria Cho(Executive Officer, Director)

BoardRose Wardle(Director)David Friedberg(Director)in

Co-investorsiSelect Fund Rabo Corporate Venturing Stray Dog Capital TPB

Upside Foodsupsidefoods.com in

Upside Foods produces cultivated meat using cell-based technology.

BiotechFoodTechSan Francisco, US

Uma Valeti(Founder)inNicholas Genovese(Founder)Will Clem(Founder)

Co-investorsAlwyn Capital BoxGroup CPT Capital Dentsu Ventures Fifty Years Future Ventures +14 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CultureHyféTriplebar

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Culture Biosciences Closes Series C Funding

Culture Biosciences · finsmes.com · Dec 16, 2025

Geltor raises venture capital to fund polypeptide expansion | Geltor

Geltor · geltor.com · Oct 13, 2025

Principals & officers · per Companies House

what is this? ⓘ

Rose Eva Wardle

LLP designated member · since 2020

Ownership & control

Rose Eva Wardle — 25–50% of voting rights

Constantinos Yiannoulis — 50–75% of voting rights, significant influence or control limited liability partnership

Frequently asked questions

How many investments has Synthesis Capital made?: Synthesis Capital has 16 tracked investments.
What stage does Synthesis Capital invest at?: Synthesis Capital invests at the Series A, Series B, Series C stages.
What sectors does Synthesis Capital focus on?: Synthesis Capital focuses on AgTech, Biotech, FoodTech, New Materials.
Where is Synthesis Capital located?: Synthesis Capital is headquartered in London, GB.
Does Synthesis Capital lead rounds?: Yes, Synthesis Capital leads investment rounds.
Who does Synthesis Capital co-invest with?: Synthesis Capital most often shares deals with Stray Dog Capital, K3 Ventures, Felicis Ventures, among 44 tracked co-investors.

Co-investors · 3

SOSV

SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.

Both backed · 4

Geltor New Culture Perfect Day Upside Foods

$30K – $550K

Mayfield Fund

Mayfield is a venture capital firm that invests in early-stage consumer and marketplace companies, backing founders from inception through IPO.

Both backed · 1

Geltor

$500K – $12M

Breakthrough Energy Ventures

Breakthrough Energy, founded by Bill Gates, backs innovators developing affordable, reliable, and clean energy technologies, investing across manufacturing, electricity, agriculture, transportation, and buildings.

Both backed · 1

Savor

$500K – $50M

Firms observed investing alongside Synthesis Capital, from public investor directories. Shared companies are the overlap with Synthesis Capital's recorded portfolio.

Similar investors

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Prime Movers Lab

Prime Movers Lab is an early-stage venture capital firm that invests in startups advancing breakthrough scientific and engineering innovations.

$2M – $30M

Forbion

Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.

Seventure Partners

Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.

Happiness Capital

Happiness Capital is a venture capital firm that invests in startups and other VC funds aligned with its values, focusing on sectors it considers crucial for the planet.